Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zuoyu (Levofolinic Acid) in unresectable or metastatic colorectal cancer
NCT05797883Phase 2Unknown
- Sponsor
- China Medical University
- Start
- Aug 2022
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
A Phase 2 trial of levoleucovorin in colorectal cancer (CRC), sponsored by China Medical University. Status: unknown.
02
Drugs
levoleucovorin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05797883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05797883.